C4 Therapeutics (CCCC) Asset Utilization Ratio (2020 - 2026)
C4 Therapeutics' quarterly Asset Utilization Ratio came in at 0.1 in Q1 2026, down 14.77% year-on-year from 0.12 in Q1 2025, and down 11.95% quarter-over-quarter from 0.12 in Q4 2025.
C4 Therapeutics has reported Asset Utilization Ratio for 7 years, with the latest figure at 0.1 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio fell 14.77% year-over-year to 0.1; the trailing twelve-month figure through Mar 2026 stood at 0.1 (down 14.77% YoY), and the FY2025 full-year result was 0.1, up 3.5% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.1, down from 0.12 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.12 in Q1 2025, with the low at 0.04 in Q2 2023.
- Average Asset Utilization Ratio over 5 years is 0.09, with a median of 0.09 recorded in 2022.
- Year-over-year, Asset Utilization Ratio sank 58.14% in 2023 and surged 129.92% in 2025.
- Tracing CCCC's Asset Utilization Ratio over 5 years: stood at 0.07 in 2022, then dropped by 16.05% to 0.06 in 2023, then jumped by 67.61% to 0.1 in 2024, then gained by 17.37% to 0.12 in 2025, then dropped by 11.95% to 0.1 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.1 (Q1 2026), 0.12 (Q4 2025), and 0.11 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.47 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.29 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.37 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.85 |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - | 0.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.10 |
| Dec 31, 2025 | 0.12 |
| Sep 30, 2025 | 0.11 |
| Jun 30, 2025 | 0.11 |
| Mar 31, 2025 | 0.12 |
| Dec 31, 2024 | 0.10 |
| Sep 30, 2024 | 0.09 |
| Jun 30, 2024 | 0.08 |
| Mar 31, 2024 | 0.05 |
| Dec 31, 2023 | 0.06 |
| Sep 30, 2023 | 0.06 |
| Jun 30, 2023 | 0.04 |
| Mar 31, 2023 | 0.07 |
| Dec 31, 2022 | 0.07 |
| Sep 30, 2022 | 0.10 |
| Jun 30, 2022 | 0.10 |
| Mar 31, 2022 | 0.09 |
| Dec 31, 2021 | 0.09 |
| Sep 30, 2021 | 0.07 |
| Jun 30, 2021 | 0.08 |
| Mar 31, 2021 | 0.09 |
| Dec 31, 2020 | 0.11 |